Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: FCA, bank competition, Glaxo

Sun, 30th Mar 2014 16:53

Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write to Chancellor George Osborne to complain about the FCA. Senior sources at four of Britain's biggest insurers told the paper Wheatley's position was untenable.Andrew Tyrie, Chairman of the Treasury Select Committee, has accused the Financial Conduct Authority of an "extraordinary blunder" in announcing market sensitive information about the insurance sector, the Sunday Telegraph reported. Insurer shares fell heavily on Friday after FCA Director of Supervision Clive Adamson told the Telegraph the watchdog planned an inquiry into pensions dating back to the 1970s. Tyrie said the FCA's pledge to bring in an external law firm to investigate the affair was not enough and that his committee would probably vet the inquiry head.The head of the Competition and Markets Authority (CMA) has said Labour leader Ed Miliband's plan for a swift breakup of Britain's banks is unworkable, the Sunday Telegraph reported. Alex Chisholm, Chief Executive of the new competition regulator, said an investigation would take at least 18 months and that any resulting disposals could take many years. Miliband said in January that a Labour government would introduce a threshold for personal current accounts and business banking and give the CMA six months to set the limit. Chisolm said the CMA, in shadow form, had been looking at small business banking for about six months.GlaxoSmithKline is planning a multimillion-pound investment in sub-Saharan Africa, the Sunday Telegraph reported. The pharmaceutical giant will announce plans to build up to five new factories on March 31st. It is looking at sites in Ghana, Ethiopia and Rwanda. Glaxo thinks Africa will be one of the fastest growing parts of the world over the next 50 years. Sub-Saharan Africa provides about £500m of Glaxo's £26.5bn annual sales.Land Securities has put on hold plans to build 200 luxury flats near Buckingham Palace until after next year's general election, the Sunday Times reported. The decision is the first sign that threats of a "mansion tax" are affecting developers' plans. The industry fears a 1% tax on homes worth more than £2m - a policy picked up by Labour that housebuilders are concerned the Conservatives will emulate.Royal Bank of Scotland is close to appointing Ewen Stevenson, one of the brains behind the 2008 banking bailout, as its new Finance Director, according to the Sunday Times. Stevenson, co-head of European investment banking at Credit Suisse, is said to have dreamt up the asset protection scheme insurance programme that stopped RBS shareholders being entirely wiped out during the financial crisis.A funding crisis has cast doubt on the future of Britain's second-biggest oil refinery, the Sunday Times said. The Stanlow plant is owned by Essar Energy, the Indian power and mining company whose founders are trying to buy it back after listing in London four years ago. Stanlow has to refinance a £330m loan from Barclays in July after using up £173m of its cash in the nine months to December. Essar said Stanlow was within its debt covenants and that the plant had the advantage of producing lots of diesel and jet fuel, of which the UK produces little.Real incomes in the UK are back to pre-financial crisis levels, the Sunday Times said. Figures in the small print of official figures released on March 28th showed real household disposable incomes were £507.7bn in the second half of last year - up 4% from the first half of 2008. Britain's population has risen in that time but by less than incomes. The figures suggest the squeeze on household budgets is easing fast.Card Factory is planning to join the line of retailers floating on the stock market with a share sale that could value the discount group at more than £700m, the Sunday Telegraph said. Its private equity owner, Charterhouse, is working on a flotation for this summer. Card Factory Chief Executive Richard Hayes told the paper he wanted to expand from 700 stores to as many as 1,100.A Chinese tycoon is in talks to buy House of Fraser for more than £450m, the Sunday Times reported. Yuan Yafei's Sanpower conglomerate has been in talks with House of Fraser for several months. The department store group's Chairman Don McCarthy has accepted the bid and has presented it to the company's other main shareholders for approval. The deal would end plans for House of Fraser to join the procession of retail initial public offerings.
More News
3 May 2023 13:03

Haleon is not losing ground to cheaper rivals, says CFO

LONDON, May 3 (Reuters) - Despite price increases, Haleon's roster of consumer health products have largely kept cheaper private-label competition at bay, Haleon chief financial officer Tobias Hestler said on Wednesday.

Read more
3 May 2023 09:19

Haleon not surprised by Pfizer stake sale plans, says CFO

LONDON, May 3 (Reuters) - Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday.

Read more
3 May 2023 07:09

Haleon Q1 profit misses analyst expectations

LONDON, May 3 (Reuters) - Haleon, the world's biggest standalone consumer health business, on Wednesday reported first-quarter profit below analyst expectations.

Read more
29 Apr 2023 15:45

US FDA panel backs restricted use of AstraZeneca's prostate cancer drug

April 28 (Reuters) - A panel of U.S. Food and Drug Administration advisers on Friday voted for the restricted use of British drugmaker AztraZeneca Plc's experimental treatment, jointly developed with Merck & Co, for a type of prostate cancer.

Read more
27 Apr 2023 10:39

GSK gets positive EU opinion for respiratory syncytial virus vaccine

(Alliance News) - GSK PLC on Thursday said its respiratory syncytial virus vaccine candidate has gained positive opinion from the European Medicines Agency body.

Read more
27 Apr 2023 10:39

IN BRIEF: Schroders taps PwC exec as CFO, GSK CFO as non-exec director

Schroders PLC - London-based investment manager - Hires Richard Oldfield to succeed Richard Keers as chief financial officer and an executive director. Oldfield currently is vice chair & global markets leader at accountants PricewaterhouseCoopers. Oldfield will join Schroders on October 2, and Keers will depart on December 31 after 10 years with the company. At Schroders, Oldfield will be responsible for "firm-wide operations" and for "financial management, risk management, technology, capital and treasury".

Read more
27 Apr 2023 08:16

EMA adopts 'positive opinion' of GSK's RSV vaccine candidate

(Sharecast News) - GSK updated the market on its respiratory syncytial virus (RSV) vaccine candidate for older adults on Thursday, reporting that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) had adopted a positive opinion by consensus.

Read more
26 Apr 2023 20:21

GSK's RSV vaccine first to get EU regulator's nod

EMA recommends authorization of first RSV vaccine

*

Read more
26 Apr 2023 17:48

European shares fall as healthcare stocks hit by drug reforms

Healthcare index marks biggest decline in 15 months

*

Read more
26 Apr 2023 17:03

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight.

Read more
26 Apr 2023 15:52

UK shareholder meetings calendar - next 7 days

Thursday 27 April 
Admiral Group PLCAGM
AFC Energy PLCAGM
Alliance Trust PLCAGM
AstraZeneca PLCAGM
BP PLCAGM
CLS Holdings PLCAGM
CRH PLCAGM
Dalata Hotel Group PLCAGM
Dial Square Investments PLCAGM
F&C Investment Trust PLCAGM
Flutter Entertainment PLCAGM
Gresham House Renewable Energy VCT 1 PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
Helios Towers PLCAGM
Ibstock PLCAGM
International Personal Finance PLCAGM
Kerry Group PLCAGM
London Stock Exchange Group PLCAGM
Pershing Square Holdings LtdAGM
Quixant PLCAGM
Robert Walters PLCAGM
Schroders PLCAGM
Serco Group PLCAGM
STV Group PLCAGM
Synectics PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Weir Group PLCAGM
Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
26 Apr 2023 14:12

EU publishes proposed drug laws overhaul, seting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

Read more
26 Apr 2023 13:24

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as HIV and respiratory medicines.

Read more
26 Apr 2023 12:03

EU publishes proposed drug laws overhaul, setting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

Read more
26 Apr 2023 09:21

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.